Karen Roy, chief business development officer for Phlexglobal, has been named a top strategist in this year’s PharmaVOICE100.
PharmaVOICE Magazine is an international publication covering the pharmaceutical industry. The magazine’s PharmaVOICE100 selects the industry’s top 100 business leaders who are setting strategic direction for their companies.
Roy joined Phlexglobal, with offices in Malvern and the UK, in 2007. Phlexglobal provides technology-enabled Trial Master File (TMF) document management solutions for companies in the global clinical research market. At Phlexglobal Roy, a pharmacist, was instrumental in developing the company’s new solution, PhlexEview.
Roy is considered a leader in knowledge of TMF best practices, standards and processes and was recognized for sharing her vision for improving clinical trial processes to shorten timelines and reduce costs. Roy’s profile is in the latest edition of PharmaVOICE.
Phlexglobal was established in 1997 and has works with both large and small organizations to help them manage both paper and electronic clinical trial documentation.
On Oct. 8 Phlexglobal will host its third US PhlexEview and eTMF user group meeting at the downtown Philadelphia Marriott. The user group brings together the eTMF user community for demos on new features and updates on industry trends.
Registration information is online at www.phlexglobal.com.
